Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

SWANBIO THERAPEUTICS LIMITED Active

Scientific & Education


Contact information


Unlock Company Insights Free Access

Get instant access to key company data, decision-maker contacts, and verified insights.

Start for Free now

Financial statements of SWANBIO THERAPEUTICS LIMITED

According to SWANBIO THERAPEUTICS LIMITED latest financial report submitted on 2023-12-31, the company has a Cash of £14M, EBITDA of £25M while the Share-Capital is £1,374.00. Compared with the previous year, the company reported a Cash increase of 51.21%, which is an equivalent of -6994907. At the same time, the EBITDA went up by 100.0%, or by -25173899.


Year:
2022 Not available
2021 Not available
2020 Not available
2019 Not available

Access 20 Years of Financial Data

Start for free
  • Reporting period

    12

  • Consolidated A/cs

    N

  • Working Capital

    £ -

EBITDA

SWANBIO THERAPEUTICS LIMITED Business Credit Report

A Business Credit Report for SWANBIO THERAPEUTICS LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for SWANBIO THERAPEUTICS LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

SWANBIO THERAPEUTICS LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

SWANBIO THERAPEUTICS LIMITED Directors and key executives

SWANBIO THERAPEUTICS LIMITED currently employs 6 people. Compared with the previous year, the company has reported a staff increase of 50%, which is an equivalent of 2 employees.
In order to view contact information, including emails and phone numbers for all the employees working at SWANBIO THERAPEUTICS LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

6

150%

1y growth

200%

2y growth

Management Level


33

Top

67

Middle

Employee Job Title Email Phone Country
James Bircher Iii Director
-
- GB
Paul Schneider Director
-
- GB
Michael Parini Director
-
- GB
John Tsai Director
-
- GB
Paul Schneider Chief Financial Officer
-
- GB

Get direct emails & phone numbers for senior executives working at «SWANBIO THERAPEUTICS LIMITED»

Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.

Install Free Browser Extension

SWANBIO THERAPEUTICS LIMITED Ownership and Group Structure


Explore the Full Corporate Tree.

Uncover parent companies, subsidiaries, and global linkages

Start Free Now

SWANBIO THERAPEUTICS LIMITED Shareholders and Ultimate Beneficial Owners (UBO)

There are currently 5 people with significant control at SWANBIO THERAPEUTICS LIMITED. One of of major shareholders of SWANBIO THERAPEUTICS LIMITED is PARTNERS INNOVATION FUND II LP, which owns 1200000 SERIES PREFERRED A shares, with a total value of 0 GBP and PARTNERS INNOVATION FUND LLC, which owns 1800000 SERIES PREFERRED A shares, with a total value of 0 GBP and SYNCONA PORTFOLIO LIMITED, which owns 74000000 SERIES PREFERRED A shares, with a total value of 0 GBP and JENNIFER CHEN, which owns 2980 GROWTH G1 shares, with a total value of 0 GBP and ANGELICA PHILLIPS, which owns 59375 GROWTH G1 shares, with a total value of 0 GBP.


Name Quantity Share Type Value
PARTNERS INNOVATION FUND II LP
1200000 SERIES PREFERRED A 0 GBP
PARTNERS INNOVATION FUND LLC
1800000 SERIES PREFERRED A 0 GBP
SYNCONA PORTFOLIO LIMITED
74000000 SERIES PREFERRED A 0 GBP
JENNIFER CHEN
2980 GROWTH G1 0 GBP
ANGELICA PHILLIPS
59375 GROWTH G1 0 GBP

See All Beneficial Owners & Shareholders

Unlock Full Access For Free

SWANBIO THERAPEUTICS LIMITED competitors:

Top 5 similar companies of SWANBIO THERAPEUTICS LIMITED are AURELIA BIOSCIENCE LTD, XENOGESIS LIMITED, APITOPE TECHNOLOGY (BRISTOL) LIMITED, IG INNOVATIONS LIMITED, BIODEXA LTD. View and export all the competitor list of SWANBIO THERAPEUTICS LIMITED by upgrading your account here.


AURELIA BIOSCIENCE LTD


Revenue
-
Age
14 years
Employees
9
Industry
View Scientific & Education
Website
View https://aure***********

XENOGESIS LIMITED


Revenue
-
Age
14 years
Employees
4
Industry
View Scientific & Education
Website
View https://xeno**********

APITOPE TECHNOLOGY (BRISTOL) LIMITED


Revenue
-
Age
23 years
Employees
1
Industry
View Scientific & Education
Website
View https://api*********

IG INNOVATIONS LIMITED


Revenue
155,000.0
Age
15 years
Employees
5
Industry
View Scientific & Education
Website
View http://ig-innov*************

BIODEXA LTD


Revenue
-
Age
25 years
Employees
4
Industry
View Scientific & Education
Website
View http://midatec************

View & Export SWANBIO THERAPEUTICS LIMITED competitors:

Get the complete list with detailed profiles

Start For Free

SWANBIO THERAPEUTICS LIMITED news & activities:


EBITDA

The SWANBIO THERAPEUTICS LIMITED-based company said the adjusted EBITDA is now £25M, compared with the previous year of 50.3 million.

uk.globaldatabase.com

2023-12-31

Employees

SWANBIO THERAPEUTICS LIMITED number of employees has increased by 50% compared with previous year and now represents a total number of 6.

uk.globaldatabase.com

2023-12-31

Stay Ahead with Real-Time Insights

Monitor key metrics and company activity

Start For Free

Frequently Asked Questions regarding SWANBIO THERAPEUTICS LIMITED


Where is SWANBIO THERAPEUTICS LIMITED registered office?

SWANBIO THERAPEUTICS LIMITED is located at Sycamore House Gunnels Wood Road, United Kingdom.

What is the website of SWANBIO THERAPEUTICS LIMITED?

SWANBIO THERAPEUTICS LIMITED website is https://swanbiotx.com/

How many people work at SWANBIO THERAPEUTICS LIMITED?

According to the latest account statement, there are currently 6 of employees working for SWANBIO THERAPEUTICS LIMITED.

What is SWANBIO THERAPEUTICS LIMITED EBITDA?

For 2023, SWANBIO THERAPEUTICS LIMITED has reported an EBITDA of £25M, which went up by 100.0% compared to previous year.

What is the Business Credit Score of SWANBIO THERAPEUTICS LIMITED and how reliable is the company?

In order to check the business credit score of SWANBIO THERAPEUTICS LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does SWANBIO THERAPEUTICS LIMITED pay their invoices on time?

By requesting a Business Credit Report for SWANBIO THERAPEUTICS LIMITED, you will be able to gain more insights about the SWANBIO THERAPEUTICS LIMITED payment trends.

Who is the Ultimate Parent of the SWANBIO THERAPEUTICS LIMITED?

Information about the ultimate beneficial ownership SYNCON***** of SWANBIO THERAPEUTICS LIMITED is available when you order a business credit report.

Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.

Get Free API Access

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action